158 related articles for article (PubMed ID: 38474177)
21. Potent antiviral activity of north-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus.
Zhu W; Burnette A; Dorjsuren D; Roberts PE; Huleihel M; Shoemaker RH; Marquez VE; Agbaria R; Sei S
Antimicrob Agents Chemother; 2005 Dec; 49(12):4965-73. PubMed ID: 16304159
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling.
Chen M; Sun F; Han L; Qu Z
Oncotarget; 2016 May; 7(22):33363-73. PubMed ID: 27166260
[TBL] [Abstract][Full Text] [Related]
23. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
Liu X; Happel C; Ziegelbauer JM
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
[TBL] [Abstract][Full Text] [Related]
25. Kaposi sarcoma-associated herpesvirus miRNAs suppress CASTOR1-mediated mTORC1 inhibition to promote tumorigenesis.
Li T; Ju E; Gao SJ
J Clin Invest; 2019 Jul; 129(8):3310-3323. PubMed ID: 31305263
[TBL] [Abstract][Full Text] [Related]
26. CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus.
Liang Z; Qin Z; Riker AI; Xi Y
Biochem Biophys Res Commun; 2020 Dec; 533(4):1400-1405. PubMed ID: 33092788
[TBL] [Abstract][Full Text] [Related]
27. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
[TBL] [Abstract][Full Text] [Related]
28. Pseudomonas aeruginosa Stimulates Inflammation and Enhances Kaposi's Sarcoma Herpesvirus-Induced Cell Proliferation and Cellular Transformation through both Lipopolysaccharide and Flagellin.
Markazi A; Bracci PM; McGrath M; Gao SJ
mBio; 2020 Nov; 11(6):. PubMed ID: 33173008
[TBL] [Abstract][Full Text] [Related]
29. Genomewide mapping and screening of Kaposi's sarcoma-associated herpesvirus (KSHV) 3' untranslated regions identify bicistronic and polycistronic viral transcripts as frequent targets of KSHV microRNAs.
Bai Z; Huang Y; Li W; Zhu Y; Jung JU; Lu C; Gao SJ
J Virol; 2014 Jan; 88(1):377-92. PubMed ID: 24155407
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma-associated herpes virus-derived microRNA K12-1 over-activates the PI3K/Akt pathway to facilitate cancer progression in HIV-related gastrointestinal Kaposi's sarcoma.
Huang X; Rao W; Wang C; Lu J; Li Z; Kong W; Feng Y; Xu T; Apaer R; Gao F
SLAS Discov; 2022 Jun; 27(4):258-265. PubMed ID: 35413475
[TBL] [Abstract][Full Text] [Related]
31. A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling.
Li W; Hu M; Wang C; Lu H; Chen F; Xu J; Shang Y; Wang F; Qin J; Yan Q; Krueger BJ; Renne R; Gao SJ; Lu C
Oncogene; 2017 Sep; 36(38):5407-5420. PubMed ID: 28534512
[TBL] [Abstract][Full Text] [Related]
32. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
Tso FY; West JT; Wood C
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362
[TBL] [Abstract][Full Text] [Related]
33. Stability of structured Kaposi's sarcoma-associated herpesvirus ORF57 protein is regulated by protein phosphorylation and homodimerization.
Majerciak V; Pripuzova N; Chan C; Temkin N; Specht SI; Zheng ZM
J Virol; 2015 Mar; 89(6):3256-74. PubMed ID: 25568207
[TBL] [Abstract][Full Text] [Related]
34. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.
Wang V; Davis DA; Deleage C; Brands C; Choi HS; Haque M; Yarchoan R
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801863
[TBL] [Abstract][Full Text] [Related]
35. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
[TBL] [Abstract][Full Text] [Related]
36. RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature.
Viollet C; Davis DA; Tekeste SS; Reczko M; Ziegelbauer JM; Pezzella F; Ragoussis J; Yarchoan R
PLoS Pathog; 2017 Jan; 13(1):e1006143. PubMed ID: 28046107
[TBL] [Abstract][Full Text] [Related]
37. Identification of Target Genes Regulated by KSHV miRNAs in KSHV-Infected Lymphoma Cells.
Quan L; Qiu T; Liang J; Li M; Zhang Y; Tao K
Pathol Oncol Res; 2015 Sep; 21(4):875-80. PubMed ID: 25648438
[TBL] [Abstract][Full Text] [Related]
38. FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.
Gao R; Li T; Tan B; Ramos da Silva S; Jung JU; Feng P; Gao SJ
J Virol; 2019 Feb; 93(3):. PubMed ID: 30404794
[TBL] [Abstract][Full Text] [Related]
39. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
[TBL] [Abstract][Full Text] [Related]
40. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
Watanabe T; Fujimuro M
Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]